Featured

  • April 14, 2026
  • North America
  • Healthcare

VB Spine Completes Transaction of Augmented Reality Spine Platform from Augmedics

NEW YORK & CHICAGO - April 13, 2026 - VB Spine LLC (“VB Spine”) completed its acquisition of exclusive rights to the xvision Spine System® (xvision) from Augmedics. …

Read More

  • April 7, 2026

H.I.G. Capital Appoints Brian Schwartz as Chief Executive Officer

MIAMI – April 7, 2026 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $74 billion of capital under management, is pleased to announce that Brian Schwartz, a longstanding member of H.I.G.’s leadership team and the firm’s Co-President,…

Read More

All Releases

Reset Filters

  • February 17, 2026
  • North America
  • Healthcare

VB Spine to acquire Augmedics’ augmented reality navigation tech

LEESBURG, VA – February 17, 2026 – VB Spine announced today that it agreed to acquire exclusive rights to the Xvision Spine System from Augmedics. The acquisition adds augmented reality (AR) navigation to the VB Spine visualization portfolio. Augmedics’ Xvision Spine System uses …

Read More

  • November 12, 2025
  • North America
  • Healthcare

Augmedics announces FDA clearance of its next-generation AR headset, X2™

CHICAGO – November 12, 2025 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced FDA 510(k) clearance of X2™, its next-generation AR headset for use with the xvision Spine System®.

Read More

  • September 17, 2025
  • North America
  • Healthcare

Highridge Medical Enters Exclusive Distribution Agreement for the PathKeeper Surgical Navigation System

WESTMINSTER, Colo., Sept. 16, 2025 (GLOBE NEWSWIRE) — Highridge Medical, one of the world’s largest privately held spine companies with an innovative and clinically supported portfolio, announced today it has entered into an exclusive distribution agreement for the PathKeeper Surgical Navigation System in the United States. The strategic agreement enhances Highridge’s

Read More

  • September 3, 2025
  • North America
  • Healthcare

Highridge Medical CEO Whitney On Accelus Buys And Spine Strategy

September 3, 2025 – Privately-owned spine specialist Highridge Medical has added three products to its portfolio following the acquisition of expandable spinal implant technologies from Accelus Medical for an undisclosed sum.

The FlareHawk and Toro expandable interbody fusion systems, and LineSider pedicle screw system, are the new additions to the spine solutions offered by Highridge Medical. The company was formed in April 2024 after its parent HIG Capital bought the bone healing (EBI range) and spine portfolios from ZimVie.

Read More

  • September 2, 2025
  • North America
  • Healthcare

Highridge Medical Acquires Innovative Products from Accelusto Expand Capabilities in Spine Surgery

WESTMINSTER, Colo., September 2, 2025 (GLOBE NEWSWIRE) — Highridge Medical, one of the world’s largest privately held spine companies with an innovative portfolio supported by extensive clinical evidence, announced today its acquisition of the FlareHawk® and Toro™ expandable interbody fusion systems, as well as the LineSider® pedicle

Read More

  • August 28, 2025
  • North America
  • Healthcare

This drug that lights up cancer cells under infrared light is making tumor removal more precise for surgeons

August 28, 2025 – “Our goal is really to get out all the cancer,” says Dr. Arvind Bakhru. In the operating room, the gynecologic oncologist relies on sight and feel to help identify the cancerous lesions he’ll remove. But at the Arizona Center for Cancer Care Gynecologic Oncology, where Bakhru practices, there has been another tool at his disposal for the past year.

Read More

  • August 7, 2025
  • North America
  • Healthcare

Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia

CT-155 showed a reduction in experiential negative symptoms as an adjunct to standard of care antipsychotic therapy from baseline to week 16, as measured by CAINS-MAP. CT-155 is an investigational prescription digital therapeutic being evaluated to target negative symptoms of schizophrenia in …

Read More

  • June 4, 2025
  • North America
  • Healthcare

Highridge Medical, an H.I.G. Capital Portfolio Company, Completes Divestiture of its Bone Healing Division

MIAMI – June 4, 2025 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $70 billion of capital under management, is pleased to announce that its portfolio company, Highridge Medical (“Highridge”), has completed the sale of its EBI Bone Healing …

Read More

  • May 8, 2025
  • North America
  • Healthcare

Exagen Inc. Prices Public Offering of Common Stock

CARLSBAD, CA – May 8, 2025 – Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3,350,000 shares of its common stock at a public offering price of $5.25 per share. …

Read More

  • April 24, 2025
  • North America
  • Healthcare

Augmedics Completes 10,000th Augmented Reality Spine Surgery With xvision Spine System

CHICAGO – April 22, 2025 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced it has treated 10,000 patients with the xvision Spine System®. The landmark achievement marks a new record for the use of augmented reality navigation …

Read More

Displaying 10 of 210 News Articles

×